In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

Published Date: 15 Dec 2023

MRD-negative patients, regardless of FLT3 ITD, do not benefit in the first remission following induction.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

2.

Oleanolic acid from grapes may increase chemotherapy effectiveness

3.

Mortality up for children with leukemia from lowest SES neighborhoods

4.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

5.

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot